ADRB3 and myocardial infarction: In rats, after myocardial infarction without reperfusion, nebivolol treatment prevented those changes by inhibiting heart β3-AR upregulation and other β-AR alterations, which was confirmed by the preservation of the heart inotropic positive response to isoproterenol altered in non-treated groups.